The primary objective of Project 1 is to define the mechanisms of functional impairment of HCV-specific CD8 T cells associated with viral persistence. While viral escape mutations within T cell epitopes occur in HCV immune evasion, a significant proportion of CD8 T cells in chronically infected subjects recognize HCV epitopes that do not demonstrate escape mutations. It is thus likely that functional impairment of CD8 cells specific for non-escaped epitopes is an additional important factor in HCV persistence. We propose that a comprehensive comparative analysis of HCV-specific CD8 T cell phenotype and function among patients who clear HCV infection versus those who do not, and between T cells recognizing epitopes that undergo substitution and those that do not will reveal specific molecular and cellular mechanisms of T cell unresponsiveness relevant to viral persistence. Specifically, we aim 1)To perform a set of in vitro functional analyses assessing the capacity of HCV specific CD8 T cells of various previously characterized phenotypes to produce relevant effector cytokines and to perform killer functions and 2)To develop and characterize an in vivo cytotoxic lymphocyte (CTL) assay for functional analysis of tetramer+ HCV specific CD8 cells using adoptive transfer into an established NOD/SCID/--/- system. This will allow us to directly analyze the in vivo functional effects of antibodies and/or cytokines targeted at potentially relevant cell membrane receptors on human HCV specific CD8 T cells. Using specific antagonist antibodies, candidate molecular determinants of CD8 T cell unresponsiveness will be interrogated in this novel in vivo system in which human T cells from patients are adoptively transferred into receptive immunodeficient mice. Outcomes of this interrogation will have direct translational relevance to the immunotherapy of chronic HCV infection as well as enhancing understanding of T cell impairment associated with persistent infection. Results of studies of humoral immune responses from Project 2 will be integrated to expand knowledge of the interplay between humoral and cellular immune responses to HCV in humans. We have already demonstrated that we can obtain the critical specimens required for this investigation and will be able to conduct unique longitudinal studies of adaptive immune responses in acute HCV.

Public Health Relevance

Project 1 is focused on understanding how T cells, an important arm of the immune system, are rendered ineffective in people who acquire HCV infection by comparing the function of T cells in people who control their HCV infection and those who do not. The goal is to understand the factors that permit T cell control of HCV infection to provide new means of treating people who did not successfully control the infection on their own.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI088791-03
Application #
8376005
Study Section
Special Emphasis Panel (ZAI1-BP-M)
Project Start
Project End
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
3
Fiscal Year
2012
Total Cost
$187,180
Indirect Cost
$73,046
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
von Delft, Annette; Humphreys, Isla S; Brown, Anthony et al. (2016) The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. Gut 65:112-23
Patel, Eshan U; Cox, Andrea L; Mehta, Shruti H et al. (2016) Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection. J Infect Dis 214:344-52
Vergara, Candelaria; Thio, Chloe L; Thomas, David et al. (2016) Polymorphisms in melanoma differentiation-associated gene 5 are not associated with clearance of hepatitis C virus in a European American population. Hepatology 63:1061-2
Wasilewski, Lisa N; Ray, Stuart C; Bailey, Justin R (2016) Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles. J Gen Virol 97:2883-2893
Rodrigo, Chaturaka; Eltahla, Auda A; Bull, Rowena A et al. (2016) Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia. J Infect Dis 214:1383-1389
Wasilewski, Lisa N; El-Diwany, Ramy; Munshaw, Supriya et al. (2016) A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies. J Virol 90:3773-82
Hajarizadeh, Behzad; Grady, Bart; Page, Kimberly et al. (2015) Patterns of hepatitis C virus RNA levels during acute infection: the InC3 study. PLoS One 10:e0122232
Hajarizadeh, B; Grady, B; Page, K et al. (2015) Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC3 study. J Viral Hepat 22:708-17
Bailey, Justin R; Dowd, Kimberly A; Snider, Anna E et al. (2015) CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus. J Infect Dis 212:914-23
El-Diwany, Ramy; Wasilewski, Lisa N; Witwer, Kenneth W et al. (2015) Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release. J Virol 89:9454-64

Showing the most recent 10 out of 37 publications